Search Results for 'taf study'

taf study published presentations and documents on DocSlides.

Elvitegravir-Cobicistat-TAF-FTC in Hepatitis B Coinfection

Elvitegravir-Cobicistat-TAF-FTC in Hepatitis B Coinfection

by melanie

Study 1249. Elvitegravir-Cobicistat-TAF-FTC in HIV...

Tenofovir Alafenamide (TAF)

Tenofovir Alafenamide (TAF)

by nicole

in a Single-Tablet Regimen . in Initial HIV-1 Ther...

Switch from TDF to TAF

Switch from TDF to TAF

by easyho

GS-US-292-0109 Study. GS-US-311-1089 Study. . De...

Ysgol Coedcae School Team around the family (TAF)

Ysgol Coedcae School Team around the family (TAF)

by tawny-fly

School context. Mixed, 11-16 comprehensive, urban...

Switch to E/C/F/TAF + DRV

Switch to E/C/F/TAF + DRV

by lindy-dunigan

Study GS-US-292-0119. E/C/F/TAF + DRV 800 mg QD. ...

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

by iris

ADVANCE. . Design. Primary endpoint. Proportion ...

Switching to Bictegravir

Switching to Bictegravir

by emery

/. Emtricitabine. /. Tenofovir. . Alafenamide. (...

Phase 2 of new ARVs Fostemsavir

Phase 2 of new ARVs Fostemsavir

by sportyinds

, . prodrug. of . temsavir. . (. attachment inhi...

by lindy-dunigan

from. TDF to TAF. GS-US-292-0109 Study. GS-US-31...

Comparison of INSTI vs INSTI

Comparison of INSTI vs INSTI

by mediumgeneral

QDMRK. SPRING-2. ONCEMRK. GS-US-380-1489. GS-US-38...

Brad Hare Nothing to Disclose

Brad Hare Nothing to Disclose

by beatrice

Kaiser Permanente San Francisco Medical Center. Sa...

Switch to DTG/3TC TANGO Design

Switch to DTG/3TC TANGO Design

by lam

Endpoints. Primary: proportion of patients with HI...

Any PRM at baseline Yes No

Any PRM at baseline Yes No

by lucy

39. 129. 100 . (91, 100). 98 . (95, 100). NRTI PRM...

Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112

Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112

by micah

Tenofovir. . Disoproxil. . Fumarate. to . Tenof...

HIV 2015-2016: New Agents, New Strategies

HIV 2015-2016: New Agents, New Strategies

by ellena-manuel

Learning Objectives. EARLY VS DEFERRED ART. The C...

Safety of Tenofovir

Safety of Tenofovir

by deandre922

Alafenamide. in Renal Impairment. A Pozniak. 1. ,...

Update from CROI 2023: Snippets from Seattle

Update from CROI 2023: Snippets from Seattle

by scarlett

Judith S. Currier, MD, MSc. Professor of Medicine....

Stephanie Cox Gilead Sciences

Stephanie Cox Gilead Sciences

by emery

Foster City, CA. ULTRASENSITIVE HIV-1 DRUG RESISTA...

GS-US-380-1878 GS-US-380-1844

GS-US-380-1878 GS-US-380-1844

by phoebe

GS-US-380-1961. . Switch to BIC/FTC/TAF. Design...

Last name First

Last name First

by ash

nameBirth place BirthdatePermanent residence addre...